"The Eye Care Institute of Louisville offers all eye services including LASIK, laser cataract surgery, ReSTOR lenses for distance and near vision and many other vision correction options. We offer laser surgery for medical eye conditions as well as care and surgery all eye diseases including cataract, glaucoma, diabetic eye disease and macular degeneration. We perform advanced corneal transplants. We offer routine and family eye exams and contact lens exams from our Louisville Eye Doctors. Our optical shop features the latest in designer eyewear, and you can order your contact lenses from us in person, by phone or online. We also offer Botox injections and Latisse for thicker, fuller eyelashes."

During the past decade, The Eye Care Institute conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 15 clinical trials were completed, i.e. on average, 65.2% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 13 clinical trials were completed. i.e. 144.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Eye Care Institute" #1 sponsor was "Allergan" with 4 trials, followed by "Refocus Group, Inc." with 3 trials sponsored, "Shire" with 3 trials sponsored, "John C Meyer, MD" with 2 trials sponsored and "Kala Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Eye Care Institute" #1 collaborator was "Daewoong Pharmaceutical Co. LTD." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "The Eye Care Institute" are "Presbyopia" (5 trials), "Dry Eye" (4 trials), "Dry Eye Syndromes" (3 trials), "Blepharitis" (2 trials) and "Adenoviral Conjunctivitis" (1 trials). Many other conditions were trialed in "The Eye Care Institute" in a lesser frequency.

Most popular intervention types in "The Eye Care Institute" are "Drug" (16 trials), "Device" (8 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "RGN-259" (2 trials), "Restylane Defyne" (2 trials), "SHP640" (2 trials) and "TP-03 Vehicle" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Eye Care Institute" are 24 trials for "All" genders.

Currently, there are NaN active trials in "The Eye Care Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 21 completed trials in The Eye Care Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in The Eye Care Institute, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".